The First and Only FDA-Approved Blood Test for Colorectal Cancer Screening

For your patients who are unwilling or unable to be screened by other recommended methods (colonoscopy or stool tests), now there is a blood test – Epi proColon®.

1 in 3 are still unscreened for colorectal cancer.

As a result, 60% of colorectal cancer cases are diagnosed at later stages when cancer has spread.

What You Should Know About Epi proColon:

A blood test is a convenient and patient-preferred method of testing

Has no pretest requirements: bowel prep, stool handling, or dietary/medication restrictions

Exhibits similar cancer detection rates to a fecal immunochemical test (FIT)

Detects methylated Septin 9 DNA that is associated with colorectal cancer

Epi proColon is for people who:
Are 50 years and older

Are average-risk for colon cancer

Have declined colon cancer screening by other methods

Learn more above the new FDA-approved blood test.

NAME *
EMAIL *
Epigenomics will not sell or repurpose your information for any other use.

Reach the one in three patients still unscreened for colon cancer with a blood test.

HOW DO I GET MORE INFORMATION ABOUT EPI PROCOLON?

Fill out the form above and/or visit epiprocolon.com.